Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan S Stolcpart

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Vascular Surgery|March 29, 2008
Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeonsThomas F Rehring, Ryan S Stolcpart, H Whitton Hollis, et al.
The American Journal of Managed Care|October 23, 2009
Statin adherence and mortality in patients enrolled in a secondary prevention programBrandy D McGinnis, Kari L Olson, Thomas M A Delate, et al.
Journal of Vascular Surgery|June 13, 2006
Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial diseaseThomas F Rehring, Ryan S Stolcpart, Brian G Sandhoff, et al.
Journal of Vascular Surgery|May 12, 2005
Atherosclerotic risk factor control in patients with peripheral arterial diseaseThomas F Rehring, Brian G Sandhoff, Ryan S Stolcpart, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 8, 2010
The risk for significant creatine kinase elevation with statinsRyan S Stolcpart, Kari L Olson, Thomas Delate, et al.
Journal of the American College of Nutrition|January 19, 2007
The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglyceridesLisa J Schwellenbach, Kari L Olson, Karen J McConnell, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Vascular Surgery|March 29, 2008
Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeonsThomas F Rehring, Ryan S Stolcpart, H Whitton Hollis, et al.
The American Journal of Managed Care|October 23, 2009
Statin adherence and mortality in patients enrolled in a secondary prevention programBrandy D McGinnis, Kari L Olson, Thomas M A Delate, et al.
Journal of Vascular Surgery|June 13, 2006
Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial diseaseThomas F Rehring, Ryan S Stolcpart, Brian G Sandhoff, et al.
Journal of Vascular Surgery|May 12, 2005
Atherosclerotic risk factor control in patients with peripheral arterial diseaseThomas F Rehring, Brian G Sandhoff, Ryan S Stolcpart, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 8, 2010
The risk for significant creatine kinase elevation with statinsRyan S Stolcpart, Kari L Olson, Thomas Delate, et al.
Journal of the American College of Nutrition|January 19, 2007
The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglyceridesLisa J Schwellenbach, Kari L Olson, Karen J McConnell, et al.
Pageof 1